JP2025500824A5 - - Google Patents

Info

Publication number
JP2025500824A5
JP2025500824A5 JP2024534724A JP2024534724A JP2025500824A5 JP 2025500824 A5 JP2025500824 A5 JP 2025500824A5 JP 2024534724 A JP2024534724 A JP 2024534724A JP 2024534724 A JP2024534724 A JP 2024534724A JP 2025500824 A5 JP2025500824 A5 JP 2025500824A5
Authority
JP
Japan
Application number
JP2024534724A
Other languages
Japanese (ja)
Other versions
JPWO2023121971A5 (https=
JP2025500824A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/053193 external-priority patent/WO2023121971A1/en
Publication of JP2025500824A publication Critical patent/JP2025500824A/ja
Publication of JP2025500824A5 publication Critical patent/JP2025500824A5/ja
Publication of JPWO2023121971A5 publication Critical patent/JPWO2023121971A5/ja
Pending legal-status Critical Current

Links

JP2024534724A 2021-12-20 2022-12-16 四価脂質化合物を含むナノ材料 Pending JP2025500824A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163291593P 2021-12-20 2021-12-20
US63/291,593 2021-12-20
US202263354640P 2022-06-22 2022-06-22
US63/354,640 2022-06-22
PCT/US2022/053193 WO2023121971A1 (en) 2021-12-20 2022-12-16 Nanomaterials comprising tetravalent lipid compounds

Publications (3)

Publication Number Publication Date
JP2025500824A JP2025500824A (ja) 2025-01-15
JP2025500824A5 true JP2025500824A5 (https=) 2025-12-19
JPWO2023121971A5 JPWO2023121971A5 (https=) 2025-12-19

Family

ID=85157420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534724A Pending JP2025500824A (ja) 2021-12-20 2022-12-16 四価脂質化合物を含むナノ材料

Country Status (6)

Country Link
US (1) US20240358841A1 (https=)
EP (1) EP4452926A1 (https=)
JP (1) JP2025500824A (https=)
AU (1) AU2022421708A1 (https=)
CA (1) CA3241503A1 (https=)
WO (1) WO2023121971A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12569438B2 (en) 2019-07-29 2026-03-10 Georgia Tech Research Corporation Nanomaterials containing constrained lipids and uses thereof
US12435035B2 (en) 2020-01-09 2025-10-07 Guide Therapeutics, Llc Nanomaterials
IL303845A (en) 2021-01-20 2023-08-01 Beam Therapeutics Inc Nanomaterials include a degradable property
KR20230131863A (ko) 2021-01-20 2023-09-14 빔 테라퓨틱스, 인크. 나노물질
CN121241046A (zh) * 2023-05-30 2025-12-30 解放生物股份有限公司 脂质化合物、组合物及其用途
WO2025059599A1 (en) * 2023-09-13 2025-03-20 Tessera Therapeutics, Inc. Lipid nanoparticles for delivery of therapeutic payloads to cells
WO2025193861A2 (en) * 2024-03-12 2025-09-18 Tessera Therapeutics, Inc. Lipid nanoparticles for delivery of therapeutic payloads to cells
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083272A1 (en) 1997-09-19 2003-05-01 Lahive & Cockfield, Llp Sense mrna therapy
US6670499B1 (en) * 1999-11-08 2003-12-30 Daicel Chemical Industries, Ltd. Adamantane derivatives and processes for the preparation thereof
WO2003101952A2 (en) * 2002-05-31 2003-12-11 The Regents Of The University Of California Polyamine-mediated transfection
JP2005181734A (ja) * 2003-12-19 2005-07-07 Fuji Photo Film Co Ltd 画像記録材料
AU2009238175C1 (en) 2008-04-15 2023-11-30 Arbutus Biopharma Corporation Novel lipid formulations for nucleic acid delivery
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
ES2895651T3 (es) * 2013-12-19 2022-02-22 Novartis Ag Lípidos y composiciones lipídicas para la administración de agentes activos
EP4286012A3 (en) 2015-09-17 2024-05-29 ModernaTX, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
JP7109784B2 (ja) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したCas9蛋白質
KR102547316B1 (ko) 2016-08-03 2023-06-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
JP7436990B2 (ja) * 2018-08-10 2024-02-22 国立大学法人京都大学 カチオン性脂質を用いた心筋細胞へのトランスフェクション方法
WO2020152037A1 (en) * 2019-01-24 2020-07-30 Agfa Nv Radiation curable inkjet inks for interior decoration
KR20210139265A (ko) 2019-02-13 2021-11-22 빔 테라퓨틱스, 인크. 표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법

Similar Documents

Publication Publication Date Title
JP2025500824A5 (https=)
BR102022025291A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
CN307045004S (https=)
BY13164U (https=)
CN307044975S (https=)
CN307044596S (https=)
CN307044263S (https=)
BY23963C1 (https=)
BY13150U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
CN307046430S (https=)